MAGEA4 and cancer: Additionally, MAGE-A4 may contribute to increased metastatic potential by influencing epithelial–mesenchymal transition (EMT) and enhancing cell migration, further supporting its role as a potential therapeutic target in aggressive cancers (8, 9).